Publications by authors named "Brian Irons"

Claim this Profile
B
Benefits of SGLT2 Inhibitors Beyond Glycemic Control - A Focus on Metabolic, Cardiovascular and Renal Outcomes.
Molly G Minze, Kayley J Will, Brian T Terrell, Robin L Black, Brian K Irons

Curr Diabetes Rev· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of a didactic ambulatory care pharmacy elective on student perceptions and subsequent performance in an ambulatory care advanced pharmacy practice experience.
Brian K Irons, Krystal L Edwards, Lisa M Chastain, Robin L Black, Crystal D Brown

Curr Pharm Teach Learn· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utilising Medicare annual wellness visits to implement interprofessional education in the primary care setting.
Brian Irons, Lance Evans, Renee Bogschutz, Kathryn Panasci, Grace Sun

J Interprof Care· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of intermediate or long-acting insulin versus Exenatide in type 2 diabetes mellitus patients not optimally controlled on dual oral diabetes medications.
Krystal L Edwards, Brian K Irons, Tom Xu

Pharm Pract (Granada)· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical pharmacists as key members of the patient-centered medical home: an opinion statement of the Ambulatory Care Practice and Research Network of the American College of Clinical Pharmacy.
Stefanie C Nigro, Candice L Garwood, Helen Berlie, Brian Irons, Daniel Longyhore

Pharmacotherapy· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug treatment of type 2 diabetes mellitus in patients for whom metformin is contraindicated.
Brian K Irons, Molly G Minze

Diabetes Metab Syndr Obes· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of direct renin inhibition on atherosclerotic biomarkers in patients with stable coronary artery disease and type 2 diabetes mellitus.
Brian K Irons, Alex Trujillo, Charles F Seifert, Jan S Simoni, Susan Doctolero

J Cardiovasc Pharmacol Ther· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An update in incretin-based therapy: a focus on glucagon-like peptide-1 receptor agonists.
Krystal L Edwards, Megan Stapleton, Jessica Weis, Brian K Irons

Diabetes Technol Ther· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An update in incretin-based therapy: a focus on dipeptidyl peptidase--4 inhibitors.
Brian K Irons, Jessica M Weis, Megan R Stapleton, Krystal L Edwards

Curr Diabetes Rev· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A collaborative cardiologist-pharmacist care model to improve hypertension management in patients with or at high risk for cardiovascular disease.
Brian K Irons, Gary Meyerrose, Sherry Laguardia, Kweku Hazel, Charles F Seifert

Pharm Pract (Granada)· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Removing barriers to insulin use.
Molly G Minze, Kavita Dalal, Brian K Irons

J Fam Pract· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors associated with increased hospital utilization in patients with heart failure and preserved ejection fraction.
Rachel S Crowder, Brian K Irons, Gary Meyerrose, Charles F Seifert

Pharmacotherapy· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of care of a pharmacist-managed diabetes service compared to usual care in an indigent clinic.
Brian K Irons, Charles F Seifert, Niambi A Horton

Diabetes Technol Ther· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of diabetes primary care and effects on health care charges in elderly patients with diabeties.
Brian K Irons, Brandi Flemming, Charles F Seifert, Donald E Wesson

Am J Med Sci· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Third-line agent selection for patients with type 2 diabetes mellitus uncontrolled with sulfonylureas and metformin.
Krystal L Edwards, Carlos Alvarez, Brian K Irons, Jessica Fields

Pharmacotherapy· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The need for a community diabetes education curriculum for healthcare professionals.
Brian K Irons, Patricia Vickers, Christina Esperat, Gloria M Valdez, Karen A Dadich

J Contin Educ Nurs· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Planning and implementing an interdisciplinary diabetes workshop for healthcare professionals.
Gloria M Valdez, Karen A Dadich, Carol Boswell, Sharon Cannon, Brian K Irons

J Contin Educ Nurs· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opinions of West Texas pharmacists about emergency contraception.
Gary Sutkin, Brenda Grant, Brian K Irons, Tyrone F Borders

Pharm Pract (Granada)· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacy- and community-based screenings for diabetes and cardiovascular conditions in high-risk individuals.
Kathleen A Snella, Ann E Canales, Brian K Irons, Rebecca B Sleeper-Irons, Maumi C Villarreal

J Am Pharm Assoc (2003)· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipid levels and use of lipid-lowering drugs for patients in pharmacist-managed lipid clinics versus usual care in 2 VA Medical Centers.
Timothy A Mazzolini, Brian K Irons, Evans C Schell, Charles F Seifert

J Manag Care Pharm· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implications of rosiglitazone and pioglitazone on cardiovascular risk in patients with type 2 diabetes mellitus.
Brian K Irons, Ronald Shane Greene, Timothy A Mazzolini, Krystal L Edwards, Rebecca B Sleeper

Pharmacotherapy· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipid management with statins in type 2 diabetes mellitus.
Brian K Irons, Lisa A Kroon

Ann Pharmacother· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Final results of the Lung Screening Study, a randomized feasibility study of spiral CT versus chest X-ray screening for lung cancer.
John K Gohagan, Pamela M Marcus, Richard M Fagerstrom, Paul F Pinsky, Barnett S Kramer, Brian Irons

Lung Cancer· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The use of angiotensin receptor blockers in the treatment of chronic heart failure.
Brian K Irons, James P Tsikouris, Audra A Thomas

J Cardiovasc Pharmacol· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delaying the onset of type 2 diabetes mellitus in patients with prediabetes.
Brian K Irons, Timothy A Mazzolini, Ronald Shane Greene

Pharmacotherapy· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis